Report #2846742

Received Jun 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 55 yrs
State: TX
Recovered: Recovered
Vaccinated: Jun 17, 2025
Onset: Jun 17, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	UNK	—	—

Symptoms (1)

Pyrexia

Symptom narrative

fever; This spontaneous report was received from non-health proffesional and refers to 55-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions included Environmenta allergies (pollen). Concomitant therapies were not reported. On 17-Jun-2025 at 08:40, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) Injection, (dose, lot # and expiration date were not reported) as routine vaccination. On 17-Jun-2025 at 23:00, the patient experienced fever. It lasted through the night. The patient took 2 - 350 mg acetaminophen on 18-JUN-2025 at 2:00 am. The patient was fine on 18-JUN-2025 at 11:00. The patient recovered from the event of fever on 18-Jun-2025 at 11:00. The action taken with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was not applicable. The causal relationship between the event of fever and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was not reported. Lot # is being requested and will be submitted if received.

Current illness

Pollen allergy